Author: Admin

Strategy’s Michael Saylor said “We’re Back” in his latest signal on X (formerly Twitter) of the company’s likely return to Bitcoin buying.For market watchers, the post could be a strong psychological signal as Saylor has a track record of dropping cryptic weekend teasers that precede official Monday morning treasury purchase announcements. Should that record, and community interpretation, hold true, his post points to the resumption of corporate Bitcoin accumulation following a notable summer hiatus.To put the message in context, over the past two months, Strategy paused its regular weekly Bitcoin buying spree. Instead of expanding its crypto holdings, management pivoted…

Greg Fields, CEO of 12x AI, tells CB Insights how they view the market, customer needs, and their company. How do you define your market and where does your company fit into that space? We’re tackling the global mental health and wellness challenges around the world, and specifically AI mental health and wellness agent software targeting smart cities and smart nations as a sovereign solution, so that the content — what users say and do — never really leaves the smart city or smart nation, as an on-premises, co-located solution.

This article was written byFollowWith over three years of finance and consulting experience, Nikola is laser focused on finding value in North American public equities and ETF’s. His professional experience includes corporate credit risk analysis, consulting for government entities, and venture capital analysis in the med-tech space. More recently, Nikola has helped investors narrow down better options for ETF’s – every asset manager seems to have similar offerings these days. Nikola is not a licensed financial advisor and nothing in his commentary here on Seeking Alpha should be regarded as advice. All of his opinions are his own, and not…

This article was written byFollowI’m an individual investor looking to grow my wealth over the long term. I’ve tried many different styles of investing over the last 25 years and have found that buying dividend growth stocks and reinvesting the dividends is one of the easiest ways to grow wealth over the long term. Over the years, I’ve owned stocks, options, ETFs, treasury notes, and mutual funds. I operate a blog, HarvestingDividends.com, that provides information on the S&P Dividend Aristocrats and other dividend growth stocks.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies…

In trading on Friday, shares of the SLW Short Duration Income ETF (Symbol: SLWS) entered into oversold territory, changing hands as low as $100.63 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In the case of SLW Short Duration Income, the RSI reading has hit 23.6 — by comparison, the RSI reading for the S&P 500 is currently 54.0. A bullish investor could look…

Gold is making another run to retest 15-week highs of $4,697 early Thursday. Gold traders are taking advantage of an upbeat mood-led US Dollar (USD) retreat, looking past hot US core Personal Consumption Expenditures (PCE) Price Index data for July.Gold eyes US jobs data and WarshRenewed USD weakness offers the much-needed boost to Gold, following Wednesday’s pullback from near the $4,675 neighbourhood.Fading hopes of an interest rate hike by the US Federal Reserve (Fed) at its September 16.-17 monetary policy decision act as a headwind to any recovery attempts in the Greenback, even though the buck witnessed a temporary rebound following…

Gold is back in the red below $4,600 early Friday, resuming its corrective decline from 15-week highs of $4,697 earlier this week.Gold’s fate hinges on Warsh’s wordsGold bulls are consolidating the upside, awaiting Federal Reserve (Fed) Chairman Kevin Warsh’s debut at the annual Jackson Hole Symposium.In doing so, traders are continuing to take profits off the table, following the recent surge to over three-month highs. They keenly await Warsh’s words for fresh hints on whether an interest rate hike remains a possibility at the Fed’s September 16-17 monetary policy meeting.Despite hot US core Personal Consumption Expenditures (PCE) Price Index data for…

If you trade NQ, you’ve probably been told to watch the pre-market high and pre-market low.That part is easy.The harder question is: what are you actually supposed to do when price gets there?Most traders react too quickly, and that’s usually where the trouble starts.In this new video, I break down the first of 3 ways we trade pre-market levels and show you what I look for before considering a trade.The biggest mistake new traders make at these levelsWhat makes one breakout worth watching and another worth avoidingThe simple confirmation that can change the setup completely

Review Federal Reserve Chairman Kevin Warsh used his Jackson Hole speech Friday to answer critics of his muddled July news conference, delivering a clearer warning that stubborn inflation could push the Fed toward a rate hike.— Matt Peterson, “Analysis: Kevin Warsh Sharpens Inflation Warning at Jackson Hole, Signaling Possible Rate Hike,” CNBC, August 28, 2026.Kevin Warsh’s Jackson Hole speech sent U.S. stocks tumbling on Friday, but they still capped off a positive week. In his speech, Warsh reaffirmed his hawkish stance and the Fed’s commitment to a 2% inflation target. Interestingly, this is almost a direct contradiction to the Treasury…

Key PointsModerna has made an incredible comeback, surging sixfold over the past year and by around 127% over the past few weeks.The MRNA vaccine company recently announced promising news that could have major implications for its pivot toward oncology.Yet while the pandemic-era darling has made a comeback, shares could pull back as the market determines a value for its future potential.10 stocks we like better than Moderna ›Moderna (NASDAQ: MRNA) shares have made an incredible comeback this year. Up by nearly sixfold over the past 12 months, the stock, formerly one of the top COVID-19 vaccine plays, has surged thanks…